# Long-term Pain Modulation by Intravenous Esketamine in CRPS

> **NCT05212571** · NA · ENROLLING_BY_INVITATION · sponsor: **Erasmus Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Complex Regional Pain Syndromes
- CRPS (Complex Regional Pain Syndromes)

## Interventions

- **DRUG:** S-ketamine infusion inpatient setting
- **DRUG:** S-ketamine infusion outpatient setting

## Key facts

- **NCT ID:** NCT05212571
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-04-19
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05212571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05212571, "Long-term Pain Modulation by Intravenous Esketamine in CRPS". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05212571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*